The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bykasov S.A.

Herzen Moscow Oncology Research Institute of Healthcare Ministry of the Russian Federation — branch of National Medical Research Radiology Center

Chissov V.I.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Sidorov D.V.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Lozhkin M.V.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Grishin N.A.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Gastropancreatoduodenal resection in a patient with locally advanced duodenal cancer after formation of digestive bypasses

Authors:

Bykasov S.A., Chissov V.I., Sidorov D.V., Lozhkin M.V., Grishin N.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2019;8(6): 443‑446

Read: 1789 times


To cite this article:

Bykasov SA, Chissov VI, Sidorov DV, Lozhkin MV, Grishin NA. Gastropancreatoduodenal resection in a patient with locally advanced duodenal cancer after formation of digestive bypasses. P.A. Herzen Journal of Oncology. 2019;8(6):443‑446. (In Russ.)
https://doi.org/10.17116/onkolog20198061443

References:

  1. Cloyd JM, George E, Visser BC. Duodenal adenocarcinoma: advances in diagnosis and surgical management. World J Gastrointest Surg. 2016;8(3):212-221. https://doi.org/10.4240/wjgs.v8.i3.212
  2. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101(3):518-526. https://doi.org/10.1002/cncr.20404
  3. Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, Kendrick ML, Reid-Lombardo KM, Harmsen WS, Que FG. Five-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. J Gastrointest Surg. 2012;16(4):682-691. https://doi.org/10.1007/s11605-011-1808-z
  4. Yamada S, Fujii T, Takami H, Hayashi M, Niwa Y, Sugimoto H, Kodera Y. Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society. Pancreatology. 2017;17(3):S59. https://doi.org/10.1016/j.pan.2017.05.187
  5. Karapanos K, Nomikos IN. Current surgical aspects of palliative treatment for unresectable pancreatic Cancer. Cancers(Basel). 2011;3(1):636-651. https://doi.org/10.3390/cancers3010636
  6. Kanehira M, Futagawa Y, Furukawa K, Shiba H, Uwagawa T, Yanaga K. Radical resection of a primary unresectable duodenal cancer after chemotherapy using S-1 and cisplatin: report of a case. Surg Case Rep. 2017;3:34. https://doi.org/10.1186/s40792-017-0304-4
  7. Velandia C, Morales RD, Coello C, Mendoza AG, Pérez G, Aguero E. Neoadjuvant chemotherapy in locally advanced duodenal adenocarcinoma. Ecancermedicalscience. 2018;12:816. https://doi.org/10.3332/ecancer.2018.816

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.